HomeOpen Access NewsOAG 035 - July 2022

OAG 035 - July 2022

The challenge of treating genetic diseases: The example of creatine transporter deficiency

The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.

What is open source software and how does it work?

Dr John Yardley, Founder and CEO of Threads Software ponders what open source software is and how it works

ARENA2036 – co-creating leapfrog innovations beneath one roof

Dr Clemens Ackermann at ARENA2036 discusses the leapfrog innovations taking place in a variety of disciplines and in research.

Selecting for resilience and efficiency: The solution for European cattle farming

Nicolas Friggens at the French Research Institute for Agriculture, Food and Environment (INRAE) discusses cattle farming resilience and efficiency with genomics in breeding programmes

How to improve biological control agents for soil and pest management

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, explains the need for an integrated approach to improve adoption of biological control agents for soil and pest management.

Training & consultancy in effective governance, risk & compliance

Michael Wuestefeld-Gray at WuDo Solutions discusses how to deliver effective governance for the public, private and charity sectors.

EV battery research for transportation

Dave Howell, U.S. Department of Energy’s Principal Deputy Director of the Manufacturing and Energy Supply Chains Office and Director of the Vehicle Technologies Office...

The background scenario for Autonomous Shipping

Marco Molica Colella, project coordinator for AUTOSHIP, discusses the EU’s role in autonomous shipping and changing of transport emissions globally.

A gendered view on ICT and social inclusion

Dr Sarah Mohammad-Qureshi, Equality, Diversity and Inclusion Partner at The University of Law, presents a gendered view on ICT and social inclusion.

Artificial Photosynthetic Chemical Process (ARPChem) project in Japan: achievements and future challenges

Here, Professor Kazunari Domen, Shinshu University and The University of Tokyo, summarizes the 10-year ARPChem project conducted from 2012 to 2022 under the support of New Energy and Industrial Technology Development Organization (NEDO).

Cellular & biological pathways from studies on communicable diseases

Adonis Sfera and Zisis Kozlakidis provide recent insights into cellular and biological pathways from studies on communicable diseases.

Government’s next big task? Avoiding the quantum computing pitfall

David Mahdi, Chief Strategy Officer and CISO Advisor at Sectigo, explores what could be the government’s next big task and avoiding the quantum computing pitfall.

Diagnostic hubs: A short-term fix for a long-term problem?

Collette Johnson, Head of Marketing at Sanome, turns the spotlight onto diagnostic hubs. Are they a short-term fix for a long-term problem, she asks.

Stationary fuel cells reliably boosting industry growth

Frank Wolak, President and CEO, Fuel Cell and Hydrogen Energy Association, argues here that stationary fuel cells reliably boost industry growth.

What we need to make breakthroughs in dementia research

David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.

Identity central to public sector digital transformation

Ian Lowe, Head of Industry Solutions – EMEA at Okta, argues that identity is at the heart of public sector digital transformation

The link between imbalanced hormones & osteoporosis

Dr Ghazala Aziz-Scott, Hormone Specialist, examines the link between imbalanced hormones and osteoporosis and why hormone treatment is so important.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders